Distorted Gold(I)-Phosphine Complexes as Antifungal Agents.
Emily K DennisJong Hyun KimSean ParkinSamuel G AwuahSylvie Garneau-TsodikovaPublished in: Journal of medicinal chemistry (2019)
Fungi cause serious nosocomial infections including candidiasis and aspergillosis, some of which display reduced susceptibility to current antifungals. Inorganic compounds have been found to be beneficial against various medical ailments but have yet to be applied to fungal infections. Here, we explore the activity of linear and square-planar gold(I)-phosphine complexes against a panel of 28 fungal strains including Candida spp., Cryptococcus spp., Aspergillus spp., and Fusarium spp. Notably, two square-planar gold(I) complexes with excellent broad-spectrum activity display potent antifungal effects against strains of Candida auris, an emerging multidrug-resistant fungus that presents a serious global health threat. To characterize the biological activity of these gold(I) complexes, we used a series of time-kill studies, cytotoxicity and hemolysis assays, as well as whole-cell uptake and development of resistance studies.
Keyphrases
- candida albicans
- global health
- multidrug resistant
- biofilm formation
- escherichia coli
- silver nanoparticles
- healthcare
- public health
- acinetobacter baumannii
- klebsiella pneumoniae
- case control
- single cell
- cell wall
- cell therapy
- stem cells
- high throughput
- gram negative
- cystic fibrosis
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- genetic diversity
- perovskite solar cells